Cargando…
Mediterranean diet and nonalcoholic fatty liver disease
Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease, and is characterized by a wide spectrum of fat-liver disorders that can result in severe liver disease and cirrhosis. Inflammation and oxidative stress are the major risk factors involved in the pathogenes...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960814/ https://www.ncbi.nlm.nih.gov/pubmed/29785077 http://dx.doi.org/10.3748/wjg.v24.i19.2083 |
_version_ | 1783324644294524928 |
---|---|
author | Anania, Caterina Perla, Francesco Massimo Olivero, Francesca Pacifico, Lucia Chiesa, Claudio |
author_facet | Anania, Caterina Perla, Francesco Massimo Olivero, Francesca Pacifico, Lucia Chiesa, Claudio |
author_sort | Anania, Caterina |
collection | PubMed |
description | Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease, and is characterized by a wide spectrum of fat-liver disorders that can result in severe liver disease and cirrhosis. Inflammation and oxidative stress are the major risk factors involved in the pathogenesis of NAFLD. Currently, there is no consensus concerning the pharmacological treatment of NAFLD. However, lifestyle interventions based on exercise and a balanced diet for quality and quantity, are considered the cornerstone of NAFLD management. Mediterranean diet (MD), rich in polyunsaturated fats, polyphenols, vitamins and carotenoids, with their anti-inflammatory and anti-oxidant effects, has been suggested to be effective in preventing cardiovascular risk factors. In adults, MD has also been demonstrated to be efficacious in reducing the risk of metabolic syndrome. However, few studies are available on the effects of the MD in both adult and pediatric subjects with NAFLD. Thus, the aims of the present narrative review are to analyze the current clinical evidence on the impact of MD in patients with NAFLD, and to summarize the main mechanisms of action of MD components on this condition. |
format | Online Article Text |
id | pubmed-5960814 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Baishideng Publishing Group Inc |
record_format | MEDLINE/PubMed |
spelling | pubmed-59608142018-05-21 Mediterranean diet and nonalcoholic fatty liver disease Anania, Caterina Perla, Francesco Massimo Olivero, Francesca Pacifico, Lucia Chiesa, Claudio World J Gastroenterol Minireviews Nonalcoholic fatty liver disease (NAFLD) is emerging as the most common chronic liver disease, and is characterized by a wide spectrum of fat-liver disorders that can result in severe liver disease and cirrhosis. Inflammation and oxidative stress are the major risk factors involved in the pathogenesis of NAFLD. Currently, there is no consensus concerning the pharmacological treatment of NAFLD. However, lifestyle interventions based on exercise and a balanced diet for quality and quantity, are considered the cornerstone of NAFLD management. Mediterranean diet (MD), rich in polyunsaturated fats, polyphenols, vitamins and carotenoids, with their anti-inflammatory and anti-oxidant effects, has been suggested to be effective in preventing cardiovascular risk factors. In adults, MD has also been demonstrated to be efficacious in reducing the risk of metabolic syndrome. However, few studies are available on the effects of the MD in both adult and pediatric subjects with NAFLD. Thus, the aims of the present narrative review are to analyze the current clinical evidence on the impact of MD in patients with NAFLD, and to summarize the main mechanisms of action of MD components on this condition. Baishideng Publishing Group Inc 2018-05-21 2018-05-21 /pmc/articles/PMC5960814/ /pubmed/29785077 http://dx.doi.org/10.3748/wjg.v24.i19.2083 Text en ©The Author(s) 2018. Published by Baishideng Publishing Group Inc. All rights reserved. http://creativecommons.org/licenses/by-nc/4.0/ This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. |
spellingShingle | Minireviews Anania, Caterina Perla, Francesco Massimo Olivero, Francesca Pacifico, Lucia Chiesa, Claudio Mediterranean diet and nonalcoholic fatty liver disease |
title | Mediterranean diet and nonalcoholic fatty liver disease |
title_full | Mediterranean diet and nonalcoholic fatty liver disease |
title_fullStr | Mediterranean diet and nonalcoholic fatty liver disease |
title_full_unstemmed | Mediterranean diet and nonalcoholic fatty liver disease |
title_short | Mediterranean diet and nonalcoholic fatty liver disease |
title_sort | mediterranean diet and nonalcoholic fatty liver disease |
topic | Minireviews |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5960814/ https://www.ncbi.nlm.nih.gov/pubmed/29785077 http://dx.doi.org/10.3748/wjg.v24.i19.2083 |
work_keys_str_mv | AT ananiacaterina mediterraneandietandnonalcoholicfattyliverdisease AT perlafrancescomassimo mediterraneandietandnonalcoholicfattyliverdisease AT oliverofrancesca mediterraneandietandnonalcoholicfattyliverdisease AT pacificolucia mediterraneandietandnonalcoholicfattyliverdisease AT chiesaclaudio mediterraneandietandnonalcoholicfattyliverdisease |